26Feb/14

Immunomedics Extends Patent Life on Therapeutic Antibodies – MarketWatch

Immunomedics Extends Patent Life on Therapeutic Antibodies
MarketWatch
8,658,773, which protects a method of concentrating antibodies for subcutaneous, intramuscular or transdermal administration. The patent covers all of the Company’s therapeutic antibodies, and can also be applied to most other antibodies, permitting a 
Immunomedics to Present at Cowen and Company 34th Annual Health Care Virtual-Strategy Magazine (press release)

all 11 news articles »

26Feb/14

Transplant drugs may cause body to reject new lungs – Futurity: Research News


GPB

Transplant drugs may cause body to reject new lungs
Futurity: Research News
Researchers found mice were more likely to reject newly transplanted lungs if key immune cells were missing, a situation that simulates what happens when patients take immunosuppressive drugs. These “memory T cells” are primed to “remember” 
New clues found to preventing lung transplant rejectionWashington University in St. Louis News

all 45 news articles »

26Feb/14

Immunomedics to Present at Cowen and Company 34th Annual Health Care … – Virtual-Strategy Magazine (press release)

Immunomedics to Present at Cowen and Company 34th Annual Health Care
Virtual-Strategy Magazine (press release)
We have developed a number of advanced proprietary technologies that allow us to create humanized antibodies that can be used either alone in unlabeled or “naked” form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins, 

and more »